Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Insurance
    • HC notice to SBI on...

    HC notice to SBI on plea for reimbursing cancer drug cost

    Written by Ruby Khatun Khatun Published On 2017-05-02T11:26:14+05:30  |  Updated On 16 Aug 2021 5:44 PM IST

    Mumbai: The Bombay High Court has sought the SBI stand on a senior citizen's plea for reimbursement of Rs six lakh as the cost of importing a cancer medicine for his wife, who was an employee of the bank.


    A bench of Justice Anoop Mohta issued the notice to the SBI on a plea by Pune resident Nagesh Marathe, who told the court that the bank refused to reimburse the cost of medicine imported from Belgium for his wife Ranjana, who worked for the the bank's Pune branch from 1983 till she died in June 2015.


    On Marathe's plea, the bench issued notice to the bank last week and posted the matter for further hearing on May 3.


    The petitioner told the court that though the medicine was procured from Belgium at Rs 6.10 lakh, it was never administered to the patient as her health deteriorated and she died.


    Marathe submitted to the court in his petition that he had applied to the SBI for reimbursement of the consultation fees and the costs of medicines and specialised investigation totalling Rs 6.33 lakh.


    "The bank, however, said it would reimburse only Rs two lakh of the entire bill and denied reimbursement of the remaining amount stating that importing medicine was not allowed and not required as the same treatment was available even in India," the petition said.


    The petitioner said that since 2013 when Ranjana was diagnosed with the cancer and the treatment was initiated, the bank paid all her bills on a regular basis.


    "In May 2015, however, Ranjana's health deteriorated and her doctor explained the need to administer a life-saving drug Kadcyla TMD-I, which was not available in India then. The treating oncologist instructed the petitioners to import the said medicine as the last resort to save Ranjana's life," the petition said.


    "The petitioners inquired and found a company, which helped them procure 18 vials of the medicine from a supplier in Belgium. The petitioners paid a sum of Rs 6.10 lakh for the medicine," it claimed.


    Marathe has sought the high court's direction to the bank to reimburse the cost with interest.


    It also sought necessary directions to hand over the medicines imported by the petitioners to the needy patients or hospitals.

    Anoop MohtaBelgiumBombay High Courtcancer drug costcancer medicinesKadcyla TMD-Ilife saving drugNagesh MaratheNoticePuneRanjanareimburseRs 6 lakhSBI
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok